{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T02:29:36Z","timestamp":1790562576110,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Patients with craniopharyngioma often have comorbidities, such as obesity and hypopituitarism. These two conditions affect each other and worsen the quality of life of patients, which lead to a higher risk of morbidity and mortality. In addition, abdominal obesity, measured as waist circumference (WC), is together with other parameters [arterial hypertension, hyperglycemia, hypertriglyceridemia, and reduced levels of high-density lipoprotein (HDL) cholesterol], one of the components of metabolic syndrome (MS). Each one of these morbidities occurs in patients with craniopharyngioma more frequently than in the remaining population. On these bases, we evaluated metabolic parameters in patients with craniopharyngioma at the time of diagnosis and after a 5-year follow-up, which compares these data with those of age-, gender-, WC-, and body mass index (BMI)-matched controls. In addition, we evaluated the prevalence of MS according to IDF criteria (MS-IDF) and the prevalence of MS according to ATP III (MS-ATPIII) criteria in patients and controls at baseline and after 5 years. We recruited 20 patients with craniopharyngioma (age 38.5 \u00b1 15 years, 10 M) and 20 age-, gender-, WC- and BMI-matched controls (age 34.16 \u00b1 13.19 years, 10 M). In all patients and controls, we evaluated the following: anthropometric features [height, weight, BMI, WC, hip circumference (HC) and waist-to-hip ratio (WHR)], systolic blood pressure (SBP) and diastolic blood pressure (DBP), lipid profile [total cholesterol (TC), HDL, low-density lipoprotein (LDL) cholesterol, triglycerides (TG)], and blood glucose at baseline and after 5 years. The prevalence of MS, according to IDF and ATPIII criteria, was calculated in the two groups at baseline and after 5 years. According to our results, at baseline, patients with craniopharyngioma had a worse metabolic profile than controls and a higher prevalence of MS. Besides, at a 5-year follow-up, patients still had impaired metabolic characteristics and more frequent MS (according to IDF and ATPIII criteria) when compared to controls. These data confirm that MS in patients with craniopharyngioma is unresponsive to life-changing interventions and to a common pharmacological approach. Other factors may be involved in the evolution of these conditions; so, further studies are needed to establish the correct management of these patients.<\/jats:p>","DOI":"10.3389\/fneur.2022.783737","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:16:49Z","timestamp":1646824609000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Craniopharyngioma and Metabolic Syndrome: A 5-Year Follow-Up Single-Center Experience"],"prefix":"10.3389","volume":"13","author":[{"given":"Elisabetta","family":"Scarano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Solari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Arianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Somma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Maria","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiammetta","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Di Somma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1210\/jc.2003-031751","article-title":"Longitudinal study on growth and BMI before and after diagnosis of childhood craniopharyngioma","volume":"89","author":"Muller","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3171\/jns.1969.30.4.0377","article-title":"Management of craniopharyngioma in childhood","volume":"30","author":"Matson","year":"1969","journal-title":"J Neurosurg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11102-006-0413-8","article-title":"Craniopharyngioma","volume":"9","author":"Jane JA","year":"2006","journal-title":"Pituitary."},{"key":"B4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.2478\/raon-2019-0036","article-title":"Advances in the management of craniopharyngioma in children and adults","volume":"53","author":"Jensterle","year":"2019","journal-title":"Radiol Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/er.2006-0002","article-title":"Craniopharyngiomas","volume":"27","author":"Karavitaki","year":"2006","journal-title":"Endocr Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/00006123-199412000-00001","article-title":"Craniopharyngiomas: a clinic o pathological analysis of factors predictive of recurrence and functional outcome","volume":"35","author":"Weiner","year":"1994","journal-title":"Neurosurgery."},{"key":"B8","first-page":"293","article-title":"Squamous cell nests of the pituitary gland as related to the origin of craniopharyngiomas: a study of their presence in the newborn and infants up to age four","volume":"70","author":"Goldberg","year":"1960","journal-title":"Arch Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/path.1700690120","article-title":"Squamous metaplasia of cells of the anterior pituitary gland","volume":"69","author":"Hunter","year":"1955","journal-title":"J Pathol Bacteriol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s12672-010-0041-7","article-title":"CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas","volume":"1","author":"Campanini","year":"2010","journal-title":"Horm Cancer."},{"key":"B11","doi-asserted-by":"publisher","first-page":"11482","DOI":"10.1073\/pnas.1101553108","article-title":"Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans","volume":"108","author":"Gaston-Massuet","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3171\/2010.11.JNS10670","article-title":"Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series","volume":"114","author":"Mortini","year":"2011","journal-title":"J Neurosurg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1824-7288-37-38","article-title":"Obesity and craniopharyngioma","volume":"16","author":"Iughetti","year":"2011","journal-title":"Ital J Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fendo.2011.00060","article-title":"Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment","volume":"2","author":"Lustig","year":"2011","journal-title":"Front Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00381-009-1078-1","article-title":"Energy expenditure in obesity associated with craniopharyngioma","volume":"26","author":"Kim","year":"2010","journal-title":"Childs Nerv Syst."},{"key":"B16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/jc.2003-030442","article-title":"Features of the metabolic syndrome after childhood craniopharyngioma","volume":"89","author":"Srinivasan","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00431-010-1347-8","article-title":"Obesity, metabolic syndrome, and insulin dynamics after craniopharyngioma surgery","volume":"170","author":"Sahakitrungruang","year":"2011","journal-title":"Eur J Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/01.ATV.0000111245.75752.C6","article-title":"National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2013a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1055\/a-0641-5956","article-title":"Childhood craniopharyngioma: a 22-year challenging follow-up in a single center","volume":"50","author":"Tosta-Hernandez","year":"2018","journal-title":"Horm Metab Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2176\/nmc.ra.2015-0099","article-title":"Craniopharyngioma in children: long-term outcomes","volume":"55","author":"Steinbok","year":"2015","journal-title":"Neurol Med Chir."},{"key":"B25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.amjmed.2004.06.035","article-title":"Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage","volume":"118","author":"Daousi","year":"2005","journal-title":"Am J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1530\/EJE-09-0449","article-title":"Hypothalamic involvement predicts cardiovascular risk in adults with childhood onset Craniopharyngioma on long-term GH therapy","volume":"161","author":"Holmer","year":"2009","journal-title":"Eur J Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"694213","DOI":"10.3389\/fendo.2021.694213","article-title":"Risk factors for hypothalamic obesity in patients with adult-onset Craniopharyngioma: a consecutive series of 120 cases","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature."},{"key":"B30","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40618-014-0196-0","article-title":"Analysis of short- and long-term metabolic effects of growth hormone replacement therapy in adult patients with craniopharyngioma and non-functioning pituitary adenoma","volume":"38","author":"Profka","year":"2015","journal-title":"J Endocrinol Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-17-0387","article-title":"The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up","volume":"178","author":"Wijnen","year":"2018","journal-title":"Eur J Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.wneu.2018.08.092","article-title":"Endocrine and metabolic outcomes after transcranial and endoscopic endonasal approaches for primary resection of craniopharyngiomas","volume":"121","author":"Li","year":"2019","journal-title":"World Neurosurg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000507702","article-title":"Prevalence of endocrine and metabolic comorbidities in a national cohort of patients with Craniopharyngioma","volume":"93","author":"Jazbin\u0161ek","year":"2020","journal-title":"Horm Res Paediatr."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040487","article-title":"Biological rhythm and chronotype: new perspectives in health","author":"Montaruli","year":"2021","journal-title":"Biomolecules."},{"key":"B35","unstructured":"New ADA initiative moves beyond \u2018metabolic syndrome\u2019. \u2018Cardiometabolic risk\u2019 proposed as umbrella term for diabetes risk factors13\n            BeckleyET\n          DOC News32006"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1161\/CIRCULATIONAHA.106.176583","article-title":"Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association","volume":"113","author":"Eckel","year":"2006","journal-title":"Circulation."},{"key":"B37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1161\/01.ATV.0000126485.80373.33","article-title":"Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk?","volume":"24","author":"Lemieux","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e43269","DOI":"10.1371\/journal.pone.0043269","article-title":"Obesity is underestimated using BMI and Waist-Hip ratio in long term adult survivor of childhood cancer","volume":"7","author":"Blijdorp","year":"2012","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0162164","DOI":"10.1371\/journal.pone.0162164","article-title":"Dual x-ray absorptiometry compared with antrhometry in relation to cardiovascular risk factors in a young adult population: is the gold standard tarnished","volume":"11","author":"Demmer","year":"2016","journal-title":"PLoS ONE."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.783737\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:16:53Z","timestamp":1646824613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.783737\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":39,"alternative-id":["10.3389\/fneur.2022.783737"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.783737","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"article-number":"783737"}}